CORC  > 中南大学
A triple combination of atorvastatin, celecoxib and tipifarnib strongly inhibits pancreatic cancer cells and xenograft pancreatic tumors
Ding, Ning; Cui, Xiao-Xing; Gao, Zhi; Huang, Huarong; Wei, Xingchuan; Du, Zhiyun; Lin, Yong; Shih, Weichung Joe; Rabson, Arnold B.; Conney, Allan H.
刊名International Journal of Oncology
2014
卷号44期号:6页码:2139-2145
关键词Cyclooxygenase-2 Farnesyl transferase Pancreatic cancer Ras Statin
ISSN号1019-6439
DOI10.3892/ijo.2014.2350
URL标识查看原文
WOS记录号WOS:000338694200039
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/3331157
专题中南大学
作者单位[Ding, Ning] Cent S Univ, Xiangya Hosp 2, Changsha 410011, Hunan, Peoples R China.
推荐引用方式
GB/T 7714
Ding, Ning,Cui, Xiao-Xing,Gao, Zhi,et al. A triple combination of atorvastatin, celecoxib and tipifarnib strongly inhibits pancreatic cancer cells and xenograft pancreatic tumors[J]. International Journal of Oncology,2014,44(6):2139-2145.
APA Ding, Ning.,Cui, Xiao-Xing.,Gao, Zhi.,Huang, Huarong.,Wei, Xingchuan.,...&Zheng, Xi*.(2014).A triple combination of atorvastatin, celecoxib and tipifarnib strongly inhibits pancreatic cancer cells and xenograft pancreatic tumors.International Journal of Oncology,44(6),2139-2145.
MLA Ding, Ning,et al."A triple combination of atorvastatin, celecoxib and tipifarnib strongly inhibits pancreatic cancer cells and xenograft pancreatic tumors".International Journal of Oncology 44.6(2014):2139-2145.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace